These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 20150988)

  • 1. Biomarkers in psychiatry: drawbacks and potential for misuse.
    Lakhan SE; Vieira K; Hamlat E
    Int Arch Med; 2010 Jan; 3():1. PubMed ID: 20150988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Letter to the Editor: CONVERGENCES AND DIVERGENCES IN THE ICD-11 VS. DSM-5 CLASSIFICATION OF MOOD DISORDERS.
    Cerbo AD
    Turk Psikiyatri Derg; 2021; 32(4):293-295. PubMed ID: 34964106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multi-class classification model for psychiatric disorder discrimination.
    Emre İE; Erol Ç; Taş C; Tarhan N
    Int J Med Inform; 2023 Feb; 170():104926. PubMed ID: 36442444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The potential of biomarkers in psychiatry: focus on proteomics.
    Sokolowska I; Ngounou Wetie AG; Wormwood K; Thome J; Darie CC; Woods AG
    J Neural Transm (Vienna); 2015 Aug; 122 Suppl 1():S9-18. PubMed ID: 24357051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Bipolar Illness Onset study: research protocol for the BIO cohort study.
    Kessing LV; Munkholm K; Faurholt-Jepsen M; Miskowiak KW; Nielsen LB; Frikke-Schmidt R; Ekstrøm C; Winther O; Pedersen BK; Poulsen HE; McIntyre RS; Kapczinski F; Gattaz WF; Bardram J; Frost M; Mayora O; Knudsen GM; Phillips M; Vinberg M
    BMJ Open; 2017 Jun; 7(6):e015462. PubMed ID: 28645967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ECNP consensus meeting. Bipolar depression. Nice, March 2007.
    Goodwin GM; Anderson I; Arango C; Bowden CL; Henry C; Mitchell PB; Nolen WA; Vieta E; Wittchen HU
    Eur Neuropsychopharmacol; 2008 Jul; 18(7):535-49. PubMed ID: 18501566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Precision medicine for suicidality: from universality to subtypes and personalization.
    Niculescu AB; Le-Niculescu H; Levey DF; Phalen PL; Dainton HL; Roseberry K; Niculescu EM; Niezer JO; Williams A; Graham DL; Jones TJ; Venugopal V; Ballew A; Yard M; Gelbart T; Kurian SM; Shekhar A; Schork NJ; Sandusky GE; Salomon DR
    Mol Psychiatry; 2017 Sep; 22(9):1250-1273. PubMed ID: 28809398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Understanding and predicting suicidality using a combined genomic and clinical risk assessment approach.
    Niculescu AB; Levey DF; Phalen PL; Le-Niculescu H; Dainton HD; Jain N; Belanger E; James A; George S; Weber H; Graham DL; Schweitzer R; Ladd TB; Learman R; Niculescu EM; Vanipenta NP; Khan FN; Mullen J; Shankar G; Cook S; Humbert C; Ballew A; Yard M; Gelbart T; Shekhar A; Schork NJ; Kurian SM; Sandusky GE; Salomon DR
    Mol Psychiatry; 2015 Nov; 20(11):1266-85. PubMed ID: 26283638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systematic reviews of the effectiveness of day care for people with severe mental disorders: (1) acute day hospital versus admission; (2) vocational rehabilitation; (3) day hospital versus outpatient care.
    Marshall M; Crowther R; Almaraz-Serrano A; Creed F; Sledge W; Kluiter H; Roberts C; Hill E; Wiersma D; Bond GR; Huxley P; Tyrer P
    Health Technol Assess; 2001; 5(21):1-75. PubMed ID: 11532238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenomenology of first-episode psychosis in schizophrenia, bipolar disorder, and unipolar depression: a comparative analysis.
    Rosen C; Marvin R; Reilly JL; Deleon O; Harris MS; Keedy SK; Solari H; Weiden P; Sweeney JA
    Clin Schizophr Relat Psychoses; 2012 Oct; 6(3):145-51. PubMed ID: 23006239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of response to drug therapy in psychiatric disorders.
    Stern S; Linker S; Vadodaria KC; Marchetto MC; Gage FH
    Open Biol; 2018 May; 8(5):. PubMed ID: 29794033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of suicide after suicide attempt according to coexisting psychiatric disorder: Swedish cohort study with long term follow-up.
    Tidemalm D; Långström N; Lichtenstein P; Runeson B
    BMJ; 2008 Nov; 337():a2205. PubMed ID: 19018040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinician guidelines for the treatment of psychiatric disorders with nutraceuticals and phytoceuticals: The World Federation of Societies of Biological Psychiatry (WFSBP) and Canadian Network for Mood and Anxiety Treatments (CANMAT) Taskforce.
    Sarris J; Ravindran A; Yatham LN; Marx W; Rucklidge JJ; McIntyre RS; Akhondzadeh S; Benedetti F; Caneo C; Cramer H; Cribb L; de Manincor M; Dean O; Deslandes AC; Freeman MP; Gangadhar B; Harvey BH; Kasper S; Lake J; Lopresti A; Lu L; Metri NJ; Mischoulon D; Ng CH; Nishi D; Rahimi R; Seedat S; Sinclair J; Su KP; Zhang ZJ; Berk M
    World J Biol Psychiatry; 2022 Jul; 23(6):424-455. PubMed ID: 35311615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between alcohol and substance use disorders and all-cause and cause-specific mortality in schizophrenia, bipolar disorder, and unipolar depression: a nationwide, prospective, register-based study.
    Hjorthøj C; Østergaard ML; Benros ME; Toftdahl NG; Erlangsen A; Andersen JT; Nordentoft M
    Lancet Psychiatry; 2015 Sep; 2(9):801-8. PubMed ID: 26277044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Diagnostic structured interviews in child and adolescent's psychiatry].
    Renou S; Hergueta T; Flament M; Mouren-Simeoni MC; Lecrubier Y
    Encephale; 2004; 30(2):122-34. PubMed ID: 15107714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Precision medicine for mood disorders: objective assessment, risk prediction, pharmacogenomics, and repurposed drugs.
    Le-Niculescu H; Roseberry K; Gill SS; Levey DF; Phalen PL; Mullen J; Williams A; Bhairo S; Voegtline T; Davis H; Shekhar A; Kurian SM; Niculescu AB
    Mol Psychiatry; 2021 Jul; 26(7):2776-2804. PubMed ID: 33828235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Applications of blood-based protein biomarker strategies in the study of psychiatric disorders.
    Chan MK; Gottschalk MG; Haenisch F; Tomasik J; Ruland T; Rahmoune H; Guest PC; Bahn S
    Prog Neurobiol; 2014 Nov; 122():45-72. PubMed ID: 25173695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biomarkers of psychiatric diseases: current status and future prospects.
    Kalia M; Costa E Silva J
    Metabolism; 2015 Mar; 64(3 Suppl 1):S11-5. PubMed ID: 25467847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. On the transdiagnostic nature of peripheral biomarkers in major psychiatric disorders: A systematic review.
    Pinto JV; Moulin TC; Amaral OB
    Neurosci Biobehav Rev; 2017 Dec; 83():97-108. PubMed ID: 28986182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Precision psychiatry with immunological and cognitive biomarkers: a multi-domain prediction for the diagnosis of bipolar disorder or schizophrenia using machine learning.
    Fernandes BS; Karmakar C; Tamouza R; Tran T; Yearwood J; Hamdani N; Laouamri H; Richard JR; Yolken R; Berk M; Venkatesh S; Leboyer M
    Transl Psychiatry; 2020 May; 10(1):162. PubMed ID: 32448868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.